标题
Monitoring Melanoma Using Circulating Free DNA
作者
关键词
-
出版物
AMERICAN JOURNAL OF CLINICAL DERMATOLOGY
Volume -, Issue -, Pages -
出版商
Springer Nature America, Inc
发表日期
2018-10-29
DOI
10.1007/s40257-018-0398-x
参考文献
相关参考文献
注意：仅列出部分参考文献，下载原文获取全部文献信息。- Evaluation of a Rapid, Fully Automated Platform for Detection of BRAF and NRAS Mutations in Melanoma
- (2018) F Barel et al. ACTA DERMATO-VENEREOLOGICA
- Fe-Au Nanoparticle-Coupling for Ultrasensitive Detections of Circulating Tumor DNA
- (2018) Ping Hu et al. ADVANCED MATERIALS
- Circulating tumoral DNA: Preanalytical validation and quality control in a diagnostic laboratory
- (2018) Sergey Nikolaev et al. ANALYTICAL BIOCHEMISTRY
- Circulating Tumor DNA: Measurement and Clinical Utility
- (2018) Joshua Donaldson et al. Annual Review of Medicine
- Correlation between circulating tumour DNA and metabolic tumour burden in metastatic melanoma patients
- (2018) Ashleigh C. McEvoy et al. BMC CANCER
- The characteristics of ctDNA reveal the high complexity in matching the corresponding tumor tissues
- (2018) Nong Yang et al. BMC CANCER
- Characterization of metastatic urothelial carcinoma via comprehensive genomic profiling of circulating tumor DNA
- (2018) Neeraj Agarwal et al. CANCER
- Liquid Biopsies and Cancer Immunotherapy
- (2018) Jonathan R. Thompson et al. CANCER JOURNAL
- Melanoma circulating tumor cells: Benefits and challenges required for clinical application
- (2018) G. Marsavela et al. CANCER LETTERS
- The role of circulating tumour cells and nucleic acids in blood for the detection of bladder cancer: A systematic review
- (2018) Pramit Khetrapal et al. CANCER TREATMENT REVIEWS
- Comprehensive Characterization of Cancer Driver Genes and Mutations
- (2018) Matthew H. Bailey et al. CELL
- The Landscape of Actionable Genomic Alterations in Cell-Free Circulating Tumor DNA from 21,807 Advanced Cancer Patients
- (2018) Oliver A. Zill et al. CLINICAL CANCER RESEARCH
- Clinical Utility of Cell-Free DNA for the Detection ofALKFusions and Genomic Mechanisms of ALK Inhibitor Resistance in Non–Small Cell Lung Cancer
- (2018) Caroline E. McCoach et al. CLINICAL CANCER RESEARCH
- The identification and isolation of CTCs: A biological Rubik’s cube
- (2018) Cristina Mansilla et al. CRITICAL REVIEWS IN ONCOLOGY HEMATOLOGY
- Plasma total cell-free DNA (cfDNA) is a surrogate biomarker for tumour burden and a prognostic biomarker for survival in metastatic melanoma patients
- (2018) S. Valpione et al. EUROPEAN JOURNAL OF CANCER
- Circulating cell-free nucleic acids: characteristics and applications
- (2018) Ondrej Pös et al. EUROPEAN JOURNAL OF HUMAN GENETICS
- Circulating tumor DNA in blood: Future genomic biomarkers for cancer detection
- (2018) Sumbal Sumbal et al. EXPERIMENTAL HEMATOLOGY
- Molecular classification and subtype-specific characterization of skin cutaneous melanoma by aggregating multiple genomic platform data
- (2018) Xiaofan Lu et al. JOURNAL OF CANCER RESEARCH AND CLINICAL ONCOLOGY
- A review on the Idylla platform: towards the assessment of actionable genomic alterations in one day
- (2018) Arnaud Uguen et al. JOURNAL OF CLINICAL PATHOLOGY
- Genetic profiling of cancer with circulating tumor DNA analysis
- (2018) Ling Lu et al. Journal of Genetics and Genomics
- Analytical Validation of a Hybrid Capture–Based Next-Generation Sequencing Clinical Assay for Genomic Profiling of Cell-Free Circulating Tumor DNA
- (2018) Travis A. Clark et al. JOURNAL OF MOLECULAR DIAGNOSTICS
- Evaluating Circulating Tumor DNA From the Cerebrospinal Fluid of Patients With Melanoma and Leptomeningeal Disease
- (2018) Leomar Y Ballester et al. JOURNAL OF NEUROPATHOLOGY AND EXPERIMENTAL NEUROLOGY
- Encorafenib plus binimetinib versus vemurafenib or encorafenib in patients with BRAF -mutant melanoma (COLUMBUS): a multicentre, open-label, randomised phase 3 trial
- (2018) Reinhard Dummer et al. LANCET ONCOLOGY
- Illustrative cases for monitoring by quantitative analysis of BRAF/NRAS ctDNA mutations in liquid biopsies of metastatic melanoma patients who gained clinical benefits from anti-PD1 antibody therapy
- (2018) Teofila Seremet et al. MELANOMA RESEARCH
- Liquid biomarkers in melanoma: detection and discovery
- (2018) Su Yin Lim et al. Molecular Cancer
- Cell-Free eccDNAs: A New Type of Nucleic Acid Component for Liquid Biopsy?
- (2018) Jing Zhu et al. Molecular Diagnosis & Therapy
- Implementation of next generation sequencing technology for somatic mutation detection in routine laboratory practice
- (2018) Tindaro Giardina et al. PATHOLOGY
- Molecular signatures of circulating melanoma cells for monitoring early response to immune checkpoint therapy
- (2018) Xin Hong et al. PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA
- Targeted Next-Generation Sequencing in Men with Metastatic Prostate Cancer: a Pilot Study
- (2018) Pedro C. Barata et al. Targeted Oncology
- Comparison of targeted next generation sequencing (NGS) versus isolated BRAF V600E analysis in patients with metastatic melanoma
- (2018) Meng-Lei Zhu et al. VIRCHOWS ARCHIV
- Whole-exome sequencing of cell-free DNA and circulating tumor cells in multiple myeloma
- (2018) S. Manier et al. Nature Communications
- Circulating Tumor DNA Genomics Correlate with Resistance to Abiraterone and Enzalutamide in Prostate Cancer
- (2018) Matti Annala et al. Cancer Discovery
- Comparison of 4 commercial kits for the extraction of circulating DNA from plasma
- (2018) Kristina Warton et al. Cancer Genetics
- Quantitative monitoring of circulating tumor DNA predicts response of cutaneous metastatic melanoma to anti-PD1 immunotherapy
- (2018) Guillaume Herbreteau et al. Oncotarget
- Evaluation of pre-analytical factors affecting plasma DNA analysis
- (2018) Havell Markus et al. Scientific Reports
- Liquid biopsy by NGS: differential presence of exons (DPE) in cell-free DNA reveals different patterns in metastatic and nonmetastatic colorectal cancer
- (2018) Susana Olmedillas-López et al. Cancer Medicine
- Biomarkers for Clinical Benefit of Immune Checkpoint Inhibitor Treatment—A Review From the Melanoma Perspective and Beyond
- (2018) Kristina Buder-Bakhaya et al. Frontiers in Immunology
- Association Between Circulating Tumor DNA and Pseudoprogression in Patients With Metastatic Melanoma Treated With Anti–Programmed Cell Death 1 Antibodies
- (2018) Jenny H. Lee et al. JAMA Oncology
- Melanoma Immunotherapy: Next-Generation Biomarkers
- (2018) Sabrina A. Hogan et al. Frontiers in Oncology
- Personalized Medicine in Malignant Melanoma: Towards Patient Tailored Treatment
- (2018) Hildur Helgadottir et al. Frontiers in Oncology
- Blood-based tumor mutational burden as a predictor of clinical benefit in non-small-cell lung cancer patients treated with atezolizumab
- (2018) David R. Gandara et al. NATURE MEDICINE
- Clinical potential of circulating tumour DNA in patients receiving anticancer immunotherapy
- (2018) Luc Cabel et al. Nature Reviews Clinical Oncology
- Extracellular vesicles and their nucleic acids for biomarker discovery
- (2018) Fatemeh Momen-Heravi et al. PHARMACOLOGY & THERAPEUTICS
- Evaluation of commercial kits for purification of circulating free DNA
- (2018) Russell J. Diefenbach et al. Cancer Genetics
- Latest development of liquid biopsy
- (2018) Alvin Ho-Kwan Cheung et al. Journal of Thoracic Disease
- Somatic mutation analysis in melanoma using targeted next generation sequencing
- (2017) Allen P. Miraflor et al. EXPERIMENTAL AND MOLECULAR PATHOLOGY
- Droplet-based digital PCR and next generation sequencing for monitoring circulating tumor DNA: a cancer diagnostic perspective
- (2017) Mathilde Postel et al. EXPERT REVIEW OF MOLECULAR DIAGNOSTICS
- Next-Generation Sequencing in Oncology: Genetic Diagnosis, Risk Prediction and Cancer Classification
- (2017) Rick Kamps et al. INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES
- Circulating mutational portrait of cancer: manifestation of aggressive clonal events in both early and late stages
- (2017) Meng Yang et al. Journal of Hematology & Oncology
- Comparison of Blood Collection Tubes from Three Different Manufacturers for the Collection of Cell-Free DNA for Liquid Biopsy Mutation Testing
- (2017) Christina Alidousty et al. JOURNAL OF MOLECULAR DIAGNOSTICS
- A Comparison of Cell-Free DNA Isolation Kits
- (2017) Laure Sorber et al. JOURNAL OF MOLECULAR DIAGNOSTICS
- Concordance of Genomic Alterations by Next-Generation Sequencing in Tumor Tissue versus Circulating Tumor DNA in Breast Cancer
- (2017) Young Kwang Chae et al. MOLECULAR CANCER THERAPEUTICS
- Evaluation of Streck BCT and PAXgene Stabilised Blood Collection Tubes for Cell-Free Circulating DNA Studies in Plasma
- (2017) Kristina Warton et al. Molecular Diagnosis & Therapy
- Application of circulating tumor DNA in prospective clinical oncology trials - standardization of preanalytical conditions
- (2017) Lisanne F. van Dessel et al. Molecular Oncology
- Phylogenetic ctDNA analysis depicts early-stage lung cancer evolution
- (2017) Christopher Abbosh et al. NATURE
- Integrating liquid biopsies into the management of cancer
- (2017) Giulia Siravegna et al. Nature Reviews Clinical Oncology
- Targeted agents and immunotherapies: optimizing outcomes in melanoma
- (2017) Jason J. Luke et al. Nature Reviews Clinical Oncology
- Overall Survival with Combined Nivolumab and Ipilimumab in Advanced Melanoma
- (2017) Jedd D. Wolchok et al. NEW ENGLAND JOURNAL OF MEDICINE
- Feasibility of monitoring advanced melanoma patients using cell-free DNA from plasma
- (2017) Tara C. Gangadhar et al. Pigment Cell & Melanoma Research
- The Role of Next-Generation Sequencing in Sarcomas: Evolution From Light Microscope to Molecular Microscope
- (2017) Roman Groisberg et al. Current Oncology Reports
- Sensitive droplet digital PCR method for detection of TERT promoter mutations in cell free DNA from patients with metastatic melanoma
- (2017) Ashleigh C. McEvoy et al. Oncotarget
- Liquid biopsy in colon cancer: comparison of different circulating DNA extraction systems following absolute quantification of KRAS mutations using Intplex allele-specific PCR
- (2017) Vera Kloten et al. Oncotarget
- Plasma Circulating Tumor DNA Levels for the Monitoring of Melanoma Patients: Landscape of Available Technologies and Clinical Applications
- (2017) Benoit Busser et al. Biomed Research International
- Liquid Biopsy: Current Status and Future Perspectives
- (2017) Sonja Mader et al. Oncology Research and Treatment
- Application of liquid biopsy in precision medicine: opportunities and challenges
- (2017) Junyun Wang et al. Frontiers of Medicine
- Comparison of 2 Commercially Available Next-Generation Sequencing Platforms in Oncology
- (2017) Nicole M. Kuderer et al. JAMA Oncology
- Characterisation of the changing genomic landscape of metastatic melanoma using cell free DNA
- (2017) Anthony Cutts et al. npj Genomic Medicine
- Whole exome sequencing for determination of tumor mutation load in liquid biopsy from advanced cancer patients
- (2017) Florence Koeppel et al. PLoS One
- Towards Personalized Medicine in Melanoma: Implementation of a Clinical Next-Generation Sequencing Panel
- (2017) Blanca de Unamuno Bustos et al. Scientific Reports
- Detection of ubiquitous and heterogeneous mutations in cell-free DNA from patients with early-stage non-small-cell lung cancer
- (2016) M. Jamal-Hanjani et al. ANNALS OF ONCOLOGY
- Noninvasive diagnosis and monitoring of mutations by deep sequencing of circulating tumor DNA in esophageal squamous cell carcinoma
- (2016) Honglei Luo et al. BIOCHEMICAL AND BIOPHYSICAL RESEARCH COMMUNICATIONS
- Next generation predictive biomarkers for immune checkpoint inhibition
- (2016) Yulian Khagi et al. CANCER AND METASTASIS REVIEWS
- Origins, structures, and functions of circulating DNA in oncology
- (2016) A. R. Thierry et al. CANCER AND METASTASIS REVIEWS
- Detection of Therapeutically Targetable Driver and Resistance Mutations in Lung Cancer Patients by Next-Generation Sequencing of Cell-Free Circulating Tumor DNA
- (2016) J. C. Thompson et al. CLINICAL CANCER RESEARCH
- The Effect of Preservative and Temperature on the Analysis of Circulating Tumor DNA
- (2016) Sonya Parpart-Li et al. CLINICAL CANCER RESEARCH
- Cobimetinib combined with vemurafenib in advanced BRAFV600-mutant melanoma (coBRIM): updated efficacy results from a randomised, double-blind, phase 3 trial
- (2016) Paolo A Ascierto et al. LANCET ONCOLOGY
- The genomic landscape of cutaneous melanoma
- (2016) Tongwu Zhang et al. Pigment Cell & Melanoma Research
- Next-generation sequencing: advances and applications in cancer diagnosis
- (2016) Simona Serratì et al. OncoTargets and Therapy
- Quantification of tumor-derived cell free DNA(cfDNA) by digital PCR (DigPCR) in cerebrospinal fluid of patients with BRAFV600 mutated malignancies
- (2016) Parisa Momtaz et al. Oncotarget
- Simple, Sensitive and Accurate Multiplex Detection of Clinically Important Melanoma DNA Mutations in Circulating Tumour DNA with SERS Nanotags
- (2016) Eugene J.H. Wee et al. Theranostics
- Fragment Length of Circulating Tumor DNA
- (2016) Hunter R. Underhill et al. PLoS Genetics
- Detection of BRAF Mutations Using a Fully Automated Platform and Comparison with High Resolution Melting, Real-Time Allele Specific Amplification, Immunohistochemistry and Next Generation Sequencing Assays, for Patients with Metastatic Melanoma
- (2016) Alexandre Harlé et al. PLoS One
- Targeted Next-Generation Sequencing of Plasma DNA from Cancer Patients: Factors Influencing Consistency with Tumour DNA and Prospective Investigation of Its Utility for Diagnosis
- (2016) Pamela J. Kaisaki et al. PLoS One
- Low Input Whole-Exome Sequencing to Determine the Representation of the Tumor Exome in Circulating DNA of Non-Small Cell Lung Cancer Patients
- (2016) Steffen Dietz et al. PLoS One
- Genomic Classification of Cutaneous Melanoma
- (2015) Rehan Akbani et al. CELL
- Detection of BRAF-V600E and V600K in melanoma circulating tumour cells by droplet digital PCR
- (2015) Anna L. Reid et al. CLINICAL BIOCHEMISTRY
- Targeting oncogenic BRAF and aberrant MAPK activation in the treatment of cutaneous melanoma
- (2015) Matteo S. Carlino et al. CRITICAL REVIEWS IN ONCOLOGY HEMATOLOGY
- Beyond BRAF V600 : Clinical Mutation Panel Testing by Next-Generation Sequencing in Advanced Melanoma
- (2015) Alan E. Siroy et al. JOURNAL OF INVESTIGATIVE DERMATOLOGY
- Evolving treatment options for melanoma brain metastases
- (2015) Thankamma Ajithkumar et al. LANCET ONCOLOGY
- Sensitivity of plasma BRAFmutant and NRASmutant cell-free DNA assays to detect metastatic melanoma in patients with low RECIST scores and non-RECIST disease progression
- (2015) Gregory A. Chang et al. Molecular Oncology
- Improved Overall Survival in Melanoma with Combined Dabrafenib and Trametinib
- (2015) Caroline Robert et al. NEW ENGLAND JOURNAL OF MEDICINE
- Nivolumab in Previously Untreated Melanoma without BRAF Mutation
- (2015) Caroline Robert et al. NEW ENGLAND JOURNAL OF MEDICINE
- Detection of Clonal and Subclonal Copy-Number Variants in Cell-Free DNA from Patients with Breast Cancer Using a Massively Multiplexed PCR Methodology
- (2015) Eser Kirkizlar et al. Translational Oncology
- Application of Sequencing, Liquid Biopsies, and Patient-Derived Xenografts for Personalized Medicine in Melanoma
- (2015) M. R. Girotti et al. Cancer Discovery
- Cancer systems biology of TCGA SKCM: Efficient detection of genomic drivers in melanoma
- (2015) Jian Guan et al. Scientific Reports
- Monitoring response to therapy in melanoma by quantifying circulating tumour DNA with droplet digital PCR for BRAF and NRAS mutations
- (2015) Simon Chang-Hao Tsao et al. Scientific Reports
- Analytical and Clinical Validation of a Digital Sequencing Panel for Quantitative, Highly Accurate Evaluation of Cell-Free Circulating Tumor DNA
- (2015) Richard B. Lanman et al. PLoS One
- Towards standardisation of cell-free DNA measurement in plasma: controls for extraction efficiency, fragment size bias and quantification
- (2014) Alison S. Devonshire et al. ANALYTICAL AND BIOANALYTICAL CHEMISTRY
- Noninvasive Detection of Response and Resistance in EGFR-Mutant Lung Cancer Using Quantitative Next-Generation Genotyping of Cell-Free Plasma DNA
- (2014) G. R. Oxnard et al. CLINICAL CANCER RESEARCH
- Quantitative Cell-Free Circulating BRAFV600E Mutation Analysis by Use of Droplet Digital PCR in the Follow-up of Patients with Melanoma Being Treated with BRAF Inhibitors
- (2014) M. F. Sanmamed et al. CLINICAL CHEMISTRY
- A Meta-analysis of Somatic Mutations from Next Generation Sequencing of 241 Melanomas: A Road Map for the Study of Genes with Potential Clinical Relevance
- (2014) J. Xia et al. MOLECULAR CANCER THERAPEUTICS
- An ultrasensitive method for quantitating circulating tumor DNA with broad patient coverage
- (2014) Aaron M Newman et al. NATURE MEDICINE
- Evaluation of Exome Sequencing to Estimate Tumor Burden in Plasma
- (2014) Daniel Klevebring et al. PLoS One
- Circulating cell free DNA: Preanalytical considerations
- (2013) Safia El Messaoudi et al. CLINICA CHIMICA ACTA
- Optimizing blood collection, transport and storage conditions for cell free DNA increases access to prenatal testing
- (2013) David Wong et al. CLINICAL BIOCHEMISTRY
- Diagnostic and prognostic value of circulating tumor-related DNA in cancer patients
- (2013) Diego M Marzese et al. EXPERT REVIEW OF MOLECULAR DIAGNOSTICS
- TERT Promoter Mutations in Familial and Sporadic Melanoma
- (2013) S. Horn et al. SCIENCE
- Acquired Resistance and Clonal Evolution in Melanoma during BRAF Inhibitor Therapy
- (2013) H. Shi et al. Cancer Discovery
- A Landscape of Driver Mutations in Melanoma
- (2012) Eran Hodis et al. CELL
- Origin and quantification of circulating DNA in mice with human colorectal cancer xenografts
- (2010) Alain R. Thierry et al. NUCLEIC ACIDS RESEARCH
- Circulating mutant DNA to assess tumor dynamics
- (2008) Frank Diehl et al. NATURE MEDICINE
Discover Peeref hubs
Discuss science. Find collaborators. Network.
Join a conversationCreate your own webinar
Interested in hosting your own webinar? Check the schedule and propose your idea to the Peeref Content Team.
Create Now